Soticlestat

Generic Name: Soticlestat

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₂₃H_₂₃N_₃O_₂

CAS Number: 1429505-03-2

Unique Ingredient Identifier: 1766MU795L

Associated Conditions: -

Associated Therapies: -

Clinical Trials

A Study of Soticlestat as an Add-on Therapy in Children and Young Adults With Dravet Syndrome

Phase 3

Completed

Conditions: Dravet Syndrome (DS)

Interventions: Drug: Placebo
Drug: Soticlestat

First Posted Date: 2021-06-25

Last Posted Date: 2025-01-01

Lead Sponsor: Takeda

Target Recruit Count: 144

Registration Number: NCT04940624

Locations: 🇺🇦
CNPE Clinical Hospital Psychiatry of the Executive Body of the Kyiv City Council KCSA, Kyiv, Ukraine
🇯🇵
Kumamoto-Ezuko Medical Center for The Severely Disabled, Kumamoto-Shi, Kumamoto, Japan
🇨🇦
Alberta Childrens Hospital, Calgary, Alberta, Canada

and more 63 locations

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy